BioDelivery Sciences International Overview

  • Founded
  • 1997
Founded
  • Status
  • Public
  • Employees
  • 176
Employees
  • Stock Symbol
  • BDSI
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $4.00
  • (As of Tuesday Closing)

BioDelivery Sciences International General Information

Description

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

Contact Information

Website
www.bdsi.com
Formerly Known As
Mas Acquisition Xxiii
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Drug Delivery
Stock Exchange
NAS
Primary Office
  • 4131 ParkLake Avenue
  • Suite 225
  • Raleigh, NC 27612
  • United States
+1 (919) 000-0000

BioDelivery Sciences International Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioDelivery Sciences International Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.00 $3.89 $3.04 - $4.99 $394M 98.6M 673K $0.33

BioDelivery Sciences International Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 314,796 402,852 625,681 262,595
Revenue 164,068 156,471 111,389 55,640
EBITDA 49,942 40,495 12,567 (17,765)
Net Income 33,880 25,711 (15,305) (33,867)
Total Assets 250,327 239,894 182,905 108,533
Total Debt 78,626 78,452 58,568 51,652
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BioDelivery Sciences International Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioDelivery Sciences International‘s full profile, request access.

Request a free trial

BioDelivery Sciences International Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated
Pharmaceuticals
Raleigh, NC
176 As of 2020
00000
000000 - 000

000000 0

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia des
0000 00000000
San Diego, CA
00 As of 0000
00.000
000000000 -

00000 00

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore m
000000000000000
Chandler, AZ
00 As of 0000
000.00
0000000000.
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioDelivery Sciences International Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SCILEX Pharmaceuticals Formerly Angel backed San Diego, CA 00 00.000 000000000 -
00000 000000000000 Corporation Chandler, AZ 00 000.00 0000000000.
0000000 0000000000 Formerly VC-backed Solana Beach, CA 000000&0
00000 Formerly VC-backed Uppsala, Sweden 000 000.00 00000000 000.00
000000000000 Corporation Staines-Upon-Thames, United Kingdom 0000 00.00 0000000000.
You’re viewing 5 of 24 competitors. Get the full list »

BioDelivery Sciences International Executive Team (15)

Name Title Board Seat Contact Info
Scott Plesha Executive & President
Mary Theresa Coelho Executive Vice President and Chief Financial Officer
James Vollins General Counsel, Legal & Secretary, Administration
Thomas Smith Chief Medical Officer
Jeffrey Bailey Chief Executive Officer & Board Member
You’re viewing 5 of 15 executive team members. Get the full list »

BioDelivery Sciences International Board Members (17)

Name Representing Role Since
0000000 000000 Self Chief Executive Officer & Board Member 000 0000
00000 000000 Self Board Member 000 0000
0000 00000 00.0 Self Board Member & Vice Chairman 000 0000
00000 000000000 Self Chairman & Board Member 000 0000
0000 00000 Self Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

BioDelivery Sciences International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioDelivery Sciences International Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioDelivery Sciences International‘s full profile, request access.

Request a free trial

BioDelivery Sciences International Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00. 00000'0 000000 09-Sep-2021 000000000 00000 00 0000 Buildings and Property
0000000 08-Dec-2016 000000000000000000 Other Healthcare 0000 00000 00.0
Arius Pharmaceuticals 24-Aug-2004 Merger/Acquisition Pharmaceuticals 0000000 0'0000000 00.
To view BioDelivery Sciences International’s complete investments and acquisitions history, request access »

BioDelivery Sciences International Subsidiaries (1)

Company Name Industry Location Founded
0000000 Other Healthcare Raleigh, NC
To view BioDelivery Sciences International’s complete subsidiaries history, request access »